CLEVELAND, Ohio — Seven in 10 people now survive their cancer five years or longer, up from only half in the mid-1970s, ...

Researchers at Queen Mary's Barts Cancer Institute have found a more active approach to monitoring and treating people with a ...

Long-term survival data further support nivolumab plus ipilimumab as first-line standard of care for patients with inoperable liver cancer.

year survival rates averaged across all cancers have never been higher, with 7-in-10 cancer patients living past 5 years post-diagnosis.

Dementia today occupies the same stigmatized, system-neglected space that cancer did half a century ago. And history shows us that stigma, not simply the absence of cures, delays progress.

The 5-year relative survival rate for all cancers continued to increase in the US in recent years with prevention and treatment improvements.

The findings, from a retrospective study of the largest UK cohort of patients with this condition to date, offer an encouraging sign of progress in ...

As soon as the urologist said, oh it’s cancer…that is an eye-opener,” says Mark Stiegler, reflecting on his diagnosis six ...

References: 1.  Thailand Food and Drug Administration. Public Pharmaceutical Regulatory Information: NERLYNX. Available at: ...

Chemotherapy reshapes gut bacteria in ways that send powerful signals throughout the body. These signals reprogram immune cells, making organs like the liver more resistant to metastatic cancer.

The researchers examined the five leading causes of cancer death among the under-50 age group. They found that overall, from 1990 through 2023, more than 1.2 million people died of cancer in the ...